PepGen Inc (PEPG)
13.96
+0.47
(+3.48%)
USD |
NASDAQ |
May 21, 16:00
13.96
0.00 (0.00%)
After-Hours: 17:46
PepGen Total Liabilities (Quarterly): 28.00M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 28.00M |
| December 31, 2023 | 34.63M |
| September 30, 2023 | 38.41M |
| June 30, 2023 | 34.80M |
| March 31, 2023 | 36.20M |
| Date | Value |
|---|---|
| December 31, 2022 | 37.81M |
| September 30, 2022 | 15.52M |
| June 30, 2022 | 20.58M |
| March 31, 2022 | 16.29M |
| December 31, 2021 | 10.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.55M
Minimum
Dec 2021
38.41M
Maximum
Sep 2023
27.28M
Average
31.32M
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 85.26M |
| Vertex Pharmaceuticals Inc | 5.371B |
| Sarepta Therapeutics Inc | 2.263B |
| PTC Therapeutics Inc | 2.684B |
| Regenxbio Inc | 238.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 207.00M |
| Shareholders Equity (Quarterly) | 179.00M |